Nevirapine-induced Stevens-Johnson syndrome following HIV postexposure prophylaxis

BMJ Case Reports

Volumn , Issue , 2013, Pages

  Bannaga, Ayman ^a   Rahama, Omar ^a   Barlow, Gavin ^a  

^a HULL AND EAST YORKSHIRE HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHLORAMPHENICOL; FLUCONAZOLE; INFUSION FLUID; LAMIVUDINE; MOUTHWASH; NEVIRAPINE; STAVUDINE;

ADULT; ARTICLE; CASE REPORT; CONJUNCTIVITIS; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DRUG WITHDRAWAL; EYE REDNESS; FOLLOW UP; HETEROSEXUAL MALE; HOSPITAL DISCHARGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERSTITIAL CYSTITIS; JAPANESE ENCEPHALITIS; LYMPHOCYTE COUNT; MACULOPAPULAR RASH; MALAISE; MALE; PATIENT EDUCATION; POST EXPOSURE PROPHYLAXIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RASH; SKIN ULCER; SORE THROAT; STEVENS JOHNSON SYNDROME; SYPHILIS; TACHYCARDIA; TREATMENT RESPONSE;

EID: 84878442824     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2013-009453     Document Type: Article

References (14)

1. Deeks S. Antiretroviral treatment of HIV infected adults. BMJ 2006;332:1489-93. (Pubitemid 44365284)
2. Benn P, Fisher M, Kulasegaram R. UK guideline for the use of post-exposure prophylaxis for HIV following sexual exposure. Int J STD AIDS 2011;22:695-708.
3. Kiertiburanakul S, Sungkanuparph S, Charoenyingwattana A, et al. Risk factors for nevirapine-Associated rash among HIV-infected patients with low CD4 cell counts in resource-limited settings. Curr HIV Res 2008;6:65-9. (Pubitemid 351461023)
4. Kobayashi S, Segawa S, Kawashima M, et al. A case of symptomatic primary HIV infection. J Dermatol 2005;32:137-42. (Pubitemid 40410306)
5. Badri T, Ben Jennet S. Rash associated with secondary syphilis. N Engl J Med 2011;364:71.
6. Landovitz R, Currie J. Postexposure prophylaxis for HIV infection. N Eng J Med 2009;361:1768-75.
7. Strom B, Carson J, Halpern A, et al. A population-based study of Stevens-Johnson syndrome. Incidence and antecedent drug exposures. Arch Dermatol. 1991;127:831-8.
8. Cohn J. Recent advances in HIV infection. BMJ 1997;314:487-91.
9. Warren K, Boxwell D, Kim N, et al. Nevirapine associated Stevens-Johnson syndrome. Lancet 1998;351:567.
10. Jao J, Sturdevant M, del Rio Martin J, et al. Nevirapine induced Stevens-Johnson syndrome and fulminant hepatic failure requiring liver transplantation. Am J Transplant 2010;10:1713-16.
11. World Health Organisation. WHO: Publications: Guidelines: Post-exposure prophylaxis to prevent HIV infection: joint WHO/ILO guidelines on post-exposure prophylaxis (PEP) to prevent HIV infection. 2007. http://www.who.int (Accessed 15 Jan 2013).
12. Rey D. Post-exposure prophylaxis for HIV infection. Anti Infec Ther 2011;9:431-42.
13. Nguyen T, Khuu N, Truong P, et al. Correlation between HIV and sexual behavior, drug use, trichomoniasis and candidiasis among female sex workers in a Mekong Delta province of Vietnam. AIDS Behav 2009;13:873-80.
14. Patel S, Johnson S, Belknap S, et al. Serious adverse cutaneous and hepatic toxicities associated with nevirapine use by non-HIV-infected individuals. J Acquir Immune Defic Syndr 2004;35:120-5. (Pubitemid 38133733)